From: Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury
 | Enrolled patients (n= 370) | Early RRT (n= 192) | Late RRT (n= 178) | P-value |
---|---|---|---|---|
Demographic data | Â | Â | Â | Â |
Age (years) | 65.4 ± 15.9 | 64.1 ± 16.5 | 66.7 ± 15.2 | 0.34 |
Male (%) | 248 (67.0) | 119 (62) | 129 (72.5) | 0.04 |
DM (%) | 126 (34.1) | 63 (32.8) | 63 (35.5) | 0.68 |
Hypertension(%) | 175 (47.3) | 92 (47.9) | 83 (46.6) | 0.93 |
CHF (%) | 68 (18.4) | 44 (22.9) | 24 (13.5) | 0.02 |
CKD (%) | 92 (24.9) | 56 (29.2) | 36 (20.2) | 0.06 |
Post-operative (%) | 237 (64.1) | 113 (58.9) | 124 (69.7) | 0.03 |
Admission creatinine (mg/dL) | 2.0 ± 0.2 | 2.7 ± 1.7 | 1.5 ± 1.0 | < 0.01 |
   (μmol/L) | 176.6 ± 17.7 | 238.7 ± 150.3 | 132.6 ± 88.4 |  |
Mechanical ventilation (%) | 322 (87.0) | 163 (84.9) | 159 (89.3) | 0.27 |
Data at ICU admission | Â | Â | Â | Â |
Hematocrit (%) | 32.2 ± 9.5 | 32.3 ± 12.0 | 32.1 ± 5.9 | 0.83 |
BUN (mg/dL) | 50.7 ± 33.7 | 59.8 ± 34.1, | 41.0 ± 30.4, | 0.05 |
   (mmol/L) | 18.1 ± 12.0 | 21.3 ± 12.2 | 14.6 ± 10.9 |  |
Creatinine (mg/dL) | 2.5 ± 1.7 | 2.6 ± 1.8 | 2.3 ± 1.6 | 0.06 |
   (μ mol/L) | 221 ± 150.3 | 232.5 ± 156.5 | 200.7 ± 141.4 |  |
Albumin (g/dL) | 2.9 ± 0.7 | 3,0 ± 0.7 | 2.9 ± 0.7 | 0.08 |
   (g/L) | 29 ± 7 | 30 ± 7 | 29 ± 7 |  |
APACHE II scores | 11.3 ± 6.4 | 11.8 ± 6.6 | 10.7 ± 6.0 | 0.37 |
SOFA scores | 8.1 ± 3.8 | 8.7 ± 3.7 | 7.4 ± 3.8 | 0.18 |
SAPS III score | 63.1 ± 13.0 | 64.7 ± 7.3 | 62.2 ± 7.6 | 0.30 |
Pre-RRT data | Â | Â | Â | Â |
Hematocrit (%) | 30.0 ± 5.8 | 30.1 ± 6.3 | 29.8 ± 0.6 | 0.62 |
BUN (mg/dL) | 81 ± 40.6 | 78.2 ± 41.2 | 84.0 ± 39.8 | 0.19 |
   (mmol/L) | 28.9 ± 14.5 | 27.9 ± 14.7 | 30.0 ± 14.2 |  |
Creatinine (mg/dL) | 3.4 ± 0.4 | 3.4 ± 0.3 | 3.4 ± 0.8 | 0.17 |
   (μmol/L) | 298.8 ± 35.4 | 297.9 ± 23.9 | 299.7 ± 70.7 |  |
Albumin (g/dL) | 3.0 ± 1.2 | 3.1 ± 1.5 | 2.9 ± 0.6 | 0.09 |
   (g/L) | 30 ± 12 | 31 ± 15 | 29 ± 6 |  |
Potassium (mEq/L) | 4.8 ± 12.1 | 5.0 ± 1.0 | 4.3 ± 0.9 | 0.32 |
Lactate (mg/dL) | 3.4 ± 3.6 | 3.5 ± 3.9 | 3.1 ± 3.5 | 0.10 |
   (mmol/L) | 0.4 ± 0.4 | 0.4 ± 0.4 | 0.3 ± 0.4 |  |
GCS scores | 11.8 ± 3.7 | 11.5 ± 4.3 | 11.0 ± 4.5 | 0.72 |
Systolic blood pressure | 122.7 ± 25.7 | 122.8 ± 26.5 | 123.7 ± 25.7 | 0.84 |
Diastolic blood pressure | 61.2 ± 39.0 | 61.5 ± 14.1 | 60.1 ± 14.0 | 0.36 |
Central venous pressure | 13.8 ± 5.5 | 14.16 ± 5.9 | 13.4 ± 5.2 | 0.22 |
APACHE II scores | 13.1 ± 6.4 | 12.3 ± 7.0 | 14.0 ± 5.5 | 0.52 |
SOFA scores | 11.2 ± 3.9 | 10.8 ± 4.0 | 11.6 ± 3.7 | 0.80 |
SAPS III score | 67.3 ± 6.8 | 66.2 ± 6.7 | 68.6 ± 6.7 | 0.61 |
Indications for dialysis | Â | Â | Â | Â |
Azotemia with uremic symptoms | 265 (71.6) | 119 (62.0) | 146 (82.0) | < 0.01 |
Oligouria or anuria | 241 (65.1) | 113 (58.9) | 128 (63.0) | 0.01 |
Fluid overload | 81 (21.9) | 41 (21.4) | 40 (22.5) | 0.29 |
Electrolyte imbalance | 23 (6.2) | 8 (4.2) | 15 (8.4) | 0.14 |
Acid base imbalance | 25 (6.8) | 12 (6.4) | 13 (7.3) | 0.84 |
Rhabdomyolysis | 7 (1.9) | 5 (2.7) | 2 (1.1) | 0.51 |
Hospital mortality | 259 (70.0) | 135 (70.8) | 124 (69.7) | 0.98 |